Digital Services        F A Q


The Therapeutic Inhibitor for Epstein-Barr Virus (EBV)


DEPARTMENT : Department of Chemistry

The Therapeutic Inhibitor for Epstein-Barr Virus (EBV)
PRODUCER : Prof. Wong Ka Leung, Dr. Lung Hong Lok
LENGTH : 3 min.
ACCESS : Open to all
SUMMARY : EBV is a ubiquitous human herpes virus, which spreads through saliva. Infection is very common and most people get EBV when they were young, but they will not experience any symptoms until they get older.

As one of eight known human herpes virus types in the herpes family, EBV infects over 90% of the human population. Nasopharyngeal Cancer (NPC) is one of EBV associated cancers where the highest NPC incidence rate is found in South China including Hong Kong. Early detection and treatment contribute to a higher survival rate.

Prof. Wong and Dr. Lung have invented new EBV-specific targeted therapy which specifically kills cancer cells without affecting any normal cells. The uptake of this drug can also be traced by the fluorescent signal and that can be used for cancer cells imaging.  

  ●  Persistent link:
  ●  XML Dublin Core code for metadata harvesting
  ●  Go to the full record in the library's catalogue

Recommended for You

This video is presented here with the permission of the producers. Any downloading, storage, reproduction, and redistribution are strictly prohibited without the prior permission of the respective producers. Go to Full Disclaimer.

  For enquiries, please contact Digital and Multimedia Services Section

© 2009-2023 All rights reserved